Table 1

Distribution of valvular regurgitation at initial echocardiogram in 4825 women exposed to fenfluramine and/or dexfenfluramine

Ages
<20 (n = 25)20–29 (n = 386)30–39 (n = 900)40–49 (n = 1442)50–59 (n = 1279)60–69 (n = 610)70+ (n = 183)All ages (n = 4825)
Aortic regurgitation
 none (%)96.085.875.465.459.559.853.666.3
 trace (%)4.010.114.717.619.920.729.517.8
 mild (%)03.17.811.213.412.811.510.7
 moderate (%)01.02.05.16.65.74.94.7
 severe (%)000.110.620.550.980.550.50
Mitral regurgitation
 none (%)64.042.236.429.824.922.618.629.6
 trace (%)32.050.850.754.454.354.148.653.0
 mild (%)4.04.910.311.213.913.613.111.6
 moderate (%)01.82.24.25.58.715.34.9
 severe (%)00.260.330.491.50.984.40.91
Tricuspid regurgitation
 none (%)56.022.824.422.821.118.415.322.0
 trace (%)28.063.560.362.160.062.160.161.1
 mild (%)16.011.912.612.112.911.512.612.3
 moderate (%)01.82.62.55.26.610.44.0
 severe (%)000.110.550.701.51.60.62
-